dodecyl-diethoxy-methylsilane CAS:60317-40-0

dodecyl-diethoxy-methylsilane

Chemical Name:dodecyl-diethoxy-methylsilane
CAS.NO:60317-40-0
Synonyms:Methyldodecyldiethoxysilane; Dodecyldiethoxymethylsilane; 
DODECYLMETHYLDIETHOXYSILANE; Silane,dodecyldiethoxymethyl;
Molecular Formula:C17H38O2Si
Molecular Weight:302.56800
 
Physical and Chemical Properties:
Density:0.845;
Boiling point:140oC;
Flash point:152oC;
Index of Refraction:1.433;
 
Specification:
Appearance:Colorless transparent liquid
Purity(GC):≥96.0%
 
Packing170 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can be used as a textile finishing agent, when mixed with amine coupling agents.
It can also effectively strengthen the hydrophobicity of fabric.
It can be used in the field of soft metal lubricants, plastics modification, mold release agents, cosmetics and other industries.



We are professional dodecyl-diethoxy-methylsilane manufacturer and Silane,dodecyldiethoxymethyl supplier in China, We offer quality Methyldodecyldiethoxysilane you can fully trust, also we have India factory and producer of odecyldiethoxymethylsilane,Pls send inquiry of dodecyl-diethoxy-methylsilane CAS:60317-40-0 to info@nbinno.com if you have any interests, thank you!


Related News: Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.N-Acetyl-L-Methionine Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors.2-Chloro-4-iodopyridine CAS:153034-86-7 It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.